A detailed history of Kingdon Capital Management, L.L.C. transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Kingdon Capital Management, L.L.C. holds 1,725,000 shares of RAPT stock, worth $2.98 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
1,725,000
Previous 1,725,000 -0.0%
Holding current value
$2.98 Million
Previous $5.26 Million 34.1%
% of portfolio
0.42%
Previous 0.61%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$2.89 - $9.38 $650,250 - $2.11 Million
225,000 Added 15.0%
1,725,000 $5.26 Million
Q1 2024

May 15, 2024

BUY
$6.87 - $26.45 $3.67 Million - $14.1 Million
534,172 Added 55.31%
1,500,000 $13.5 Million
Q4 2023

Feb 14, 2024

BUY
$11.28 - $25.46 $1.8 Million - $4.07 Million
160,000 Added 19.86%
965,828 $24 Million
Q3 2023

Nov 14, 2023

SELL
$16.34 - $24.66 $3.17 Million - $4.79 Million
-194,172 Reduced 19.42%
805,828 $13.4 Million
Q2 2023

Aug 14, 2023

BUY
$16.06 - $21.61 $1.99 Million - $2.68 Million
124,016 Added 14.16%
1,000,000 $18.7 Million
Q1 2023

May 15, 2023

SELL
$17.19 - $30.8 $69,035 - $123,692
-4,016 Reduced 0.46%
875,984 $16.1 Million
Q4 2022

Feb 14, 2023

BUY
$16.28 - $24.6 $3.33 Million - $5.03 Million
204,383 Added 30.25%
880,000 $17.4 Million
Q3 2022

Nov 14, 2022

SELL
$17.96 - $30.46 $6.24 Million - $10.6 Million
-347,704 Reduced 33.98%
675,617 $16.3 Million
Q2 2022

Aug 15, 2022

SELL
$10.26 - $23.59 $666,900 - $1.53 Million
-65,000 Reduced 5.97%
1,023,321 $18.7 Million
Q1 2022

May 16, 2022

SELL
$17.02 - $40.22 $1.02 Million - $2.41 Million
-60,000 Reduced 5.23%
1,088,321 $23.9 Million
Q3 2021

Nov 15, 2021

BUY
$29.86 - $39.47 $11.3 Million - $14.9 Million
377,500 Added 48.97%
1,148,321 $35.7 Million
Q2 2021

Aug 16, 2021

BUY
$17.99 - $40.02 $9.84 Million - $21.9 Million
546,800 Added 244.08%
770,821 $24.5 Million
Q1 2021

May 17, 2021

SELL
$16.0 - $24.46 $473,392 - $723,698
-29,587 Reduced 11.67%
224,021 $4.97 Million
Q4 2020

Feb 16, 2021

BUY
$15.89 - $40.87 $4.03 Million - $10.4 Million
253,608 New
253,608 $5.01 Million

Others Institutions Holding RAPT

About RAPT Therapeutics, Inc.


  • Ticker RAPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,656,600
  • Market Cap $51.3M
  • Description
  • RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...
More about RAPT
Track This Portfolio

Track Kingdon Capital Management, L.L.C. Portfolio

Follow Kingdon Capital Management, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kingdon Capital Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Kingdon Capital Management, L.L.C. with notifications on news.